Antibacterial and antifungal action of CTAB-containing silica nanoparticles against human pathogens

[Display omitted] New antibiotic agents are urgently needed worldwide to combat the increasing tolerance and resistance of pathogenic fungi and bacteria to current antimicrobials. Here, we looked at the antibacterial and antifungal effects of minor quantities of cetyltrimethylammonium bromide (CTAB)...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of pharmaceutics Vol. 641; p. 123074
Main Authors:	Martins da Silva Filho, Pedro, Higor Rocha Mariano, Pedro, Lopes Andrade, Alexandre, Barros Arrais Cruz Lopes, Jessica, de Azevedo Pinheiro, Aryane, Itala Geronimo de Azevedo, Mayara, Carneiro de Medeiros, Suelen, Alves de Vasconcelos, Mayron, Gonçalvez da Cruz Fonseca, Said, Barbosa Grangeiro, Thalles, Gonzaga de França Lopes, Luiz, Henrique Silva Sousa, Eduardo, Holanda Teixeira, Edson, Longhinotti, Elisane
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 25-06-2023
Subjects:	Anti-Bacterial Agents - pharmacology Antifungal Agents - pharmacology Antimicrobial Cetrimonium - pharmacology Cetyltrimethylammonium bromide Humans Metal Nanoparticles Methicillin-Resistant Staphylococcus aureus Microbial Sensitivity Tests Nanoparticles Silica Silicon Dioxide - pharmacology Staphylococcus aureus Surfactant Synergistic action Nanoparticles Antimicrobial Cetyltrimethylammonium bromide Synergistic action Surfactant Silica
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!